Overview
- Examines in detail the latest developments in theranostics for neuroendocrine tumors and other diseases
- Covers a wide spectrum of topics, from radiochemistry to clinical applications
- Focuses on gallium-68 but also considers other PET radionuclides
- Includes supplementary material: sn.pub/extras
Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 194)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (34 papers)
-
Generators
-
Radiochemistry and Radiopharmacy
Keywords
About this book
Reviews
From the reviews:
“The general themes of this book (theranostics and peptide receptor–targeted radiotherapy) derive from evolving successes in the use of generator-produced 68Ga for molecular imaging of disease. … This book is an excellent resource for investigators interested in gaining a detailed understanding of the state of the art in 68Ga and peptide receptor radionuclide therapy–based theranostics for preclinical and emerging clinical applications.” (Michael K. Schultz, The Journal of Nuclear Medicine, Vol. 54 (4), April, 2013)Editors and Affiliations
Bibliographic Information
Book Title: Theranostics, Gallium-68, and Other Radionuclides
Book Subtitle: A Pathway to Personalized Diagnosis and Treatment
Editors: Richard P. Baum, Frank Rösch
Series Title: Recent Results in Cancer Research
DOI: https://doi.org/10.1007/978-3-642-27994-2
Publisher: Springer Berlin, Heidelberg
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag Berlin Heidelberg 2013
Hardcover ISBN: 978-3-642-27993-5Published: 23 August 2012
Softcover ISBN: 978-3-642-44160-8Published: 20 September 2014
eBook ISBN: 978-3-642-27994-2Published: 23 August 2012
Series ISSN: 0080-0015
Series E-ISSN: 2197-6767
Edition Number: 1
Number of Pages: XVIII, 578
Topics: Oncology, Nuclear Medicine, Neuroradiology, Radiotherapy, Molecular Medicine